Roche, Boehringer and AbbVie have strong pot portfolios: report

09-11-2018

Roche, Boehringer and AbbVie have strong pot portfolios: report

lpettet / iStockphoto.com

The strongest cannabidiol (CBD) patent portfolios are owned by Roche, Boehringer Ingelheim, and AbbVie, according to a report released earlier this week.


Clarivate Analytics, patent filings, market research, cannabis innovation, cannabidiol, pain, inflammation, global patenting activity, Roche, Boehringer

LSIPR